Inspection Record

Colonia Care Pharmacy — FDA 483 Findings

US FDAInspected 2021-07-26Published 2021-10-20 3 findingsContamination controlAseptic processing and sterility assurance

Inspectors Unnee Ranjan · Jessica S EstripletThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

2Contamination control

You produced highly potent diugs without providing adequate containment, segregation, cleaning of work surfaces, cleaning of utensils and cleaning of personnel to prevent cross-contamination.

3Aseptic processing and sterility assurance

The use of sporicidal agents in the ISO 5 classified aseptic processing area was inadequate and infrequent.

About this record

Extracted automatically from the document US FDA published on 2021-10-20. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Colonia Care Pharmacy findings history — including this company's other documentsAll US FDA findings US FDA documents, 2021 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.